MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Search

Atossa Genetics Inc

Closed

0.89 -1.11

Overview

Share price change

24h

Current

Min

0.85

Max

0.91

Key metrics

By Trading Economics

Income

-371K

-6.7M

Employees

15

EBITDA

-766K

-7.1M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+518.68% upside

Dividends

By Dow Jones

Next Earnings

11 Aug 2025

Market Stats

By TradingEconomics

Market Cap

13M

121M

Previous open

2

Previous close

0.89

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Genetics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Jul 2025, 23:56 UTC

Acquisitions, Mergers, Takeovers

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- 2nd Update

16 Jul 2025, 23:43 UTC

Acquisitions, Mergers, Takeovers

Santos 2Q Output Rises 1% as Takeover Campaign Continues

16 Jul 2025, 23:00 UTC

Acquisitions, Mergers, Takeovers

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- Update

16 Jul 2025, 22:38 UTC

Acquisitions, Mergers, Takeovers

Alimentation Couche-Tard Withdraws Seven & i Acquisition Proposal

16 Jul 2025, 23:44 UTC

Market Talk

Gold Steady; Geopolitical Tensions in Middle East Support -- Market Talk

16 Jul 2025, 23:42 UTC

Market Talk

Nikkei May Fall as Yen Strengthens -- Market Talk

16 Jul 2025, 23:24 UTC

Market Talk

Australian Job Market Data to Shape RBA Calls -- Market Talk

16 Jul 2025, 23:18 UTC

Acquisitions, Mergers, Takeovers

Santos Now Expects 2025 Production of 90 Million-95 Million BOE

16 Jul 2025, 23:18 UTC

Acquisitions, Mergers, Takeovers

Santos Cuts Top End of 2025 Production Guidance

16 Jul 2025, 23:17 UTC

Acquisitions, Mergers, Takeovers

Santos: Production Recovery Underway in Cooper Basin

16 Jul 2025, 23:17 UTC

Acquisitions, Mergers, Takeovers

Santos: Over 200 Wells, Several Upstream Compressors in Cooper Basin Shut In

16 Jul 2025, 23:17 UTC

Acquisitions, Mergers, Takeovers

Santos: Cooper Basin Production Impacted by Floods in 2Q

16 Jul 2025, 23:16 UTC

Acquisitions, Mergers, Takeovers

Santos: Pikka Phase 1 Project in Alasia 89% Complete

16 Jul 2025, 23:16 UTC

Acquisitions, Mergers, Takeovers

Santos Keeps 2025 Major Development Project Capex Guidance Unchanged

16 Jul 2025, 23:13 UTC

Acquisitions, Mergers, Takeovers

Santos Had Gearing of 20.5% at End-June, Excluding Operating Leases

16 Jul 2025, 23:13 UTC

Acquisitions, Mergers, Takeovers

Santos Says Moomba CCS Phase 1 Project Performing to Expectations

16 Jul 2025, 23:12 UTC

Acquisitions, Mergers, Takeovers

Santos Narrows 2025 Unit Production Cost Guidance to US$7.00-US$7.40/BOE

16 Jul 2025, 23:12 UTC

Acquisitions, Mergers, Takeovers

Santos 1H Free Cash Flow From Operations US$1.1 Billion

16 Jul 2025, 23:11 UTC

Acquisitions, Mergers, Takeovers

Santos 2Q Free Cash Flow From Operations US$620 Million

16 Jul 2025, 23:11 UTC

Acquisitions, Mergers, Takeovers

Santos 2Q Oil, Natural Gas Output 22.2 Million BOE

16 Jul 2025, 23:11 UTC

Acquisitions, Mergers, Takeovers

Santos 2Q Oil, Natural Gas Sales Volumes 23.9 Million BOE

16 Jul 2025, 23:11 UTC

Acquisitions, Mergers, Takeovers

Santos 2Q Oil, Natural Gas Sales Volumes Up 3% on 1Q

16 Jul 2025, 23:11 UTC

Acquisitions, Mergers, Takeovers

Santos 2Q Oil, Natural Gas Output Up 1% on 1Q

16 Jul 2025, 22:43 UTC

Market Talk

Alcoa Using High Costs of More Production to Battle Tariff -- Market Talk

16 Jul 2025, 22:35 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

16 Jul 2025, 22:35 UTC

Market Talk
Earnings

Replacing Aluminum Imports With U.S. Production Not Seen Feasible -- Market Talk

16 Jul 2025, 22:33 UTC

Market Talk
Earnings

Alcoa Will Continue to Ship Aluminum Outside of the U.S. -- Market Talk

16 Jul 2025, 22:28 UTC

Market Talk
Earnings

Aluminum Price in U.S. Doesn't Offset Tariff Costs, Alcoa says -- Market Talk

16 Jul 2025, 22:22 UTC

Market Talk
Earnings

Market Talk Roundup: Latest on U.S. Politics

16 Jul 2025, 22:22 UTC

Market Talk
Earnings

Alcoa Considers Restart of Idle Capacity at Indiana Smelter -- Market Talk

Peer Comparison

Price change

Atossa Genetics Inc Forecast

Price Target

By TipRanks

518.68% upside

12 Months Forecast

Average 5.63 USD  518.68%

High 7.5 USD

Low 4 USD

Based on 4 Wall Street analysts offering 12 month price targets forAtossa Genetics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Atossa Genetics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.